{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:29:13Z","timestamp":1766086153742,"version":"build-2065373602"},"reference-count":0,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"name":"Association Recherche et Entraide des Maladies Lupiques"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Mediators of Inflammation"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:p><jats:italic>Background:<\/jats:italic> Platelet\u2010activating factor (PAF) seems to be implicated in systemic lupus erythematosus (SLE) patients with associated renal diseases.<jats:italic>Aims:<\/jats:italic> In this study, we ensured the role of PAF in SLE patients without renal complications.<\/jats:p><jats:p><jats:italic>Methods:<\/jats:italic> Blood PAF and acetylhydrolase activity, plasma soluble phospholipase A<jats:sub>2<\/jats:sub>, and the presence of antibodies against PAF were investigated in 17 SLE patients without active nephritis and in 17 healthy controls.<\/jats:p><jats:p><jats:italic>Results:<\/jats:italic> Blood PAF levels were not different (<jats:italic>P<\/jats:italic> = 0.45) between SLE patients (6.7\u00b12.8 pg\/ml) and healthy subjects (9.6\u00b13.1 pg\/ml). Plasma acetylhydrolase activity (the PAF\u2010degrading enzyme) was significantly (<jats:italic>P<\/jats:italic> = 0.03) elevated in SLE patients (57.8\u00b16.4 nmol\/min\/ml) as compared with controls (37.9\u00b12.6 nmol\/min\/ml). Plasma soluble phospholipase A<jats:sub>2<\/jats:sub> (the key enzyme for PAF formation) was not different (<jats:italic>P<\/jats:italic> = 0.6) between SLE patients (59.1\u00b15.1 U\/ml) and controls (54.7\u00b12.4 U\/ml). Antibodies against PAF were detected only in 3\/17 SLE patients. Flow cytometry analysis did not highlight PAF receptors on circulating leukocytes of SLE patients.<\/jats:p><jats:p><jats:italic>Conclusion:<\/jats:italic> This clinical study highlights no evidence for a putative important role of PAF in SLE patients without active nephritis.<\/jats:p>","DOI":"10.1080\/0962935031000097718","type":"journal-article","created":{"date-parts":[[2004,5,2]],"date-time":"2004-05-02T00:28:15Z","timestamp":1083457695000},"page":"101-105","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["No evidence for a putative involvement of platelet\u2010activating factor in systemic lupus erythematosus without active nephritis"],"prefix":"10.1155","volume":"12","author":[{"given":"Yves","family":"Denizot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Liozon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Ly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Loustaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Odile","family":"Jauberteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,1]]},"container-title":["Mediators of Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/mi\/2003\/657218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1080\/0962935031000097718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T11:49:17Z","timestamp":1723117757000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1080\/0962935031000097718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1080\/0962935031000097718"],"URL":"https:\/\/doi.org\/10.1080\/0962935031000097718","archive":["Portico"],"relation":{},"ISSN":["0962-9351","1466-1861"],"issn-type":[{"type":"print","value":"0962-9351"},{"type":"electronic","value":"1466-1861"}],"subject":[],"published":{"date-parts":[[2003,1]]},"assertion":[{"value":"2003-01-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}